Advertisement

Cyclodextrin derivatives and cyclofructan as ocular permeation enhancers

Results with different model compounds
  • Christian Schoch
  • Jean-Claude Bizec
  • Georg Kis
Original Article

Abstract

The positive influence of specific cyclodextrins and cyclofructan on the permeation of ophthalmic drugs through ocular tissues was demonstrated

Keywords

Peranhydro-cyclodextrins Quaternary ammonium cyclodextrins Cyclofructan Permeation enhancement Ophthalmic drugs 

References

  1. 1.
    Kaur, I.P., Kanwar, M.: Ocular preparations: the formulation approach. Drug Dev. Ind. Pharm. 28, 473–493 (2002)CrossRefGoogle Scholar
  2. 2.
    Babiole, M., Kis, G.: Development of COX 189 Eye Drops. In: 12th International Cyclodextrin Symposium, Montpellier (2004)Google Scholar
  3. 3.
    Petro, M., Kis, G., Schoch, C., Horvath, Gy., Szente, L., Szejtli, J.: Toxicological properties of quaternary amino and anhydro cyclodextrins. In: 12th International Cyclodextrin Symposium, Montpellier (2004)Google Scholar
  4. 4.
    Szeredi, A., Jicsinszky, L., Ivanyi, R., Kis, G., Schoch, C.: Some comments on the synthesis of [(2-hydroxy-3-N,N,N-trimethylamino)propyl}cyclodextrins. In: 12th International Cyclodextrin Symposium, Montpellier (2004)Google Scholar
  5. 5.
    Kis, G., Schoch, C., Bizec, J.-C.: Quaternary ammonium cyclodextrins – molecules with a wide range of applications. In: 12th International Cyclodextrin Symposium, Montpellier (2004)Google Scholar
  6. 6.
    Bizec, J.-C., Kameni, J., Babiole, M., Kis, G.: Ocular tolerability of QA-β and QA-γ-cyclodextrins. In: 12th International Cyclodextrin Symposium, Montpellier (2004)Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2007

Authors and Affiliations

  • Christian Schoch
    • 1
  • Jean-Claude Bizec
    • 2
  • Georg Kis
    • 3
  1. 1.Novartis Pharma AGBaselSwitzerland
  2. 2.Novartis Pharma AGBaselSwitzerland
  3. 3.Novartis Pharma AGBaselSwitzerland

Personalised recommendations